EICHOR
● Completed
Observational Study of Patients With Moderate to Severe Chronic Plaque Psoriasis
Condition: Chronic Plaque Psoriasis · Sponsor: AbbVie
About this study
This study will assess the use of risankizumab in adult patients with moderate to severe chronic plaque psoriasis and compare risankizumab to other commonly used biologics.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (302)
| Emiliano Baccarini Priv Practice /ID# 218581 | Lomas de Zamora, Buenos Aires, Argentina | — |
| Hospital Universitario Austral /ID# 217540 | Pilar, Buenos Aires, Argentina | — |
| Stringa Dermatologia /ID# 218450 | Ciudad Autonoma Buenos Aires, Buenos Aires F.D., Argentina | — |
| Private Office Cristina Echeverria /ID# 222082 | Ciudad Autonoma Buenos Aires, Buenos Aires F.D., Argentina | — |
| Stat Research /ID# 217185 | Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina | — |
| Buenos Aires Skin /ID# 217657 | Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina | — |
| CEDIC Centro de Investigaciones Clinicas /ID# 217184 | Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina | — |
| Instituto de Neumonologia y Dermatologia /ID# 217429 | Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina | — |
| Psoriahue Med Interdisciplinar /ID# 217182 | Ciudad Autonoma de Buenos Aire, Buenos Aires F.D., Argentina | — |
| Professional Skin Care /ID# 218514 | Buenos Aires, Argentina | — |
| Hospital Italiano /ID# 217000 | CABA, Argentina | — |
| Premier Specialist /ID# 218158 | Kogarah, New South Wales, Australia | — |
+ 290 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03982394